Indian Journal of Research in Homoeopathy (IJRH) with print ISSN: 0974-7168 and E-ISSN: 2320-7094 is an internationally acclaimed official publication of Central Council for Research in Homoeopathy, New Delhi, publishing quarterly in print as well as online. Since, first issue in 2007 we have published 13 volumes comprising 46 issues and around 275 research articles on Homoeopathy. The Journal was made open access online in July 2013 and is following rigorous double blind peer-review process to provide constructive feedback to authors to improve submission quality. To ensure wider publicity, the abstracts are published in four foreign languages viz. Spanish, French, German & Chinese.
The current focus of homoeopathic research is on the evidence-based practices and universally acknowledged parameters, with special emphasis on documentation.
The journal is committed to meet the needs of readers and authors, to constantly improve the quality of content and maintain integrity of the academic records. It is determined to handle complications transparently by publications of acknowledgements consistent with established policies. The Journal ensures that research paper published has ethical clearance, no conflict of interest and discourages plagiarism and copyright violations.
Editorial Advisory Board and reviewer’s panel of our Journal have international representation with highly acclaimed researchers, practitioners and healthcare professionals from across the globe.
Abstracting and Indexing Information
The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TdNet, Wanfang Data
The journal is indexed with, or included in, the following:
DOAJ, Index Copernicus, Scimago Journal Ranking, SCOPUS
Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp
Open Access Publication and Creative Commons Licensing
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.
Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.
CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.
Ahead of Print policy
Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:
- "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
- The Editorial Board has full and final approval over the content of all advertisements.
- Advertisers will never be shown any manuscripts or other content prior to publication.
The Journal publishes evidence based articles on homoeopathic research which has positive impact globally. The journal’s regular subscribers include homoeopathic practitioners, healthcare professionals, authors, other bio-medical researchers, medical students, policy makers and ultimately patients.
We invite scientific submissions in homoeopathy from the authors in the following categories: original, substantiated and unpublished research in all aspects of basic and applied research in homoeopathy, systematic as well as narrative reviews, case reports/series, book reviews, debates etc. Some of the areas of focus are drug standardization, drug proving, clinical verification, clinical research, extramural research and collaborative research in homoeopathy.
- On average four to five original articles per issue.
- Regularly published issues with no delay or miss
- Abstracts in Hindi, Spanish and German language for wider dissemination
- New, interesting, rare and good quality case reports
- Articles in accordance with “uniform requirements for manuscript submitted to biomedical Journals” and ICMJE guidelines
- Editorial advisory board with international and national experts/leaders
- Reports of major conferences/workshops held nationally
- Established ethical standards/policies are followed